Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nucleic Acids Res ; 49(7): 4120-4128, 2021 04 19.
Artículo en Inglés | MEDLINE | ID: mdl-33764415

RESUMEN

Cas12f, also known as Cas14, is an exceptionally small type V-F CRISPR-Cas nuclease that is roughly half the size of comparable nucleases of this type. To reveal the mechanisms underlying substrate recognition and cleavage, we determined the cryo-EM structures of the Cas12f-sgRNA-target DNA and Cas12f-sgRNA complexes at 3.1 and 3.9 Å, respectively. An asymmetric Cas12f dimer is bound to one sgRNA for recognition and cleavage of dsDNA substrate with a T-rich PAM sequence. Despite its dimerization, Cas12f adopts a conserved activation mechanism among the type V nucleases which requires coordinated conformational changes induced by the formation of the crRNA-target DNA heteroduplex, including the close-to-open transition in the lid motif of the RuvC domain. Only one RuvC domain in the Cas12f dimer is activated by substrate recognition, and the substrate bound to the activated RuvC domain is captured in the structure. Structure-assisted truncated sgRNA, which is less than half the length of the original sgRNA, is still active for target DNA cleavage. Our results expand our understanding of the diverse type V CRISPR-Cas nucleases and facilitate potential genome editing applications using the miniature Cas12f.


Asunto(s)
Proteínas Bacterianas/metabolismo , Proteínas Asociadas a CRISPR , Endodesoxirribonucleasas/metabolismo , Ácidos Nucleicos Heterodúplex/metabolismo , Proteínas Bacterianas/química , Proteínas Asociadas a CRISPR/química , Proteínas Asociadas a CRISPR/metabolismo , Sistemas CRISPR-Cas , ADN/metabolismo , División del ADN , Endodesoxirribonucleasas/química , Endodesoxirribonucleasas/farmacocinética , Edición Génica , Modelos Moleculares , Unión Proteica
2.
J Invest Dermatol ; 114(1): 149-56, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10620131

RESUMEN

Exposing human skin to ultraviolet radiation causes DNA damage, sunburn, immune alterations, and eventually, skin cancer. We wished to determine whether liposomes containing a DNA repair enzyme could prevent any of the acute effects of irradiation when applied after ultraviolet exposure. Fifteen human patients with a prior history of skin cancer were exposed to two minimal erythema doses of ultraviolet radiation on their buttock skin. Liposomes containing T4 endonuclease V or heat-inactivated enzyme were applied immediately and at 2, 4, and 5 h after ultraviolet irradiation. Transmission electron microscopy after anti-T4 endonuclease V-staining and immunogold labeling on biopsies taken at 6 h after ultraviolet exposure revealed that the enzyme was present within cells in the skin. Immunohistochemical DNA damage studies suggested a trend toward improved DNA repair at the active T4 endonuclease V liposome-treated test sites. Although the active T4 endonuclease V liposomes did not significantly affect the ultraviolet-induced erythema response and microscopic sunburn cell formation, they nearly completely prevented ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha RNA message and of interleukin-10 protein. These studies demonstrate that liposomes can be used for topical intracellular delivery of small proteins to human skin and suggest that liposomes containing DNA repair enzymes may provide a new avenue for photoprotection against some forms of ultraviolet-induced skin damage.


Asunto(s)
ADN Ligasas/administración & dosificación , Endodesoxirribonucleasas/administración & dosificación , Interleucina-10/metabolismo , Protectores contra Radiación/administración & dosificación , Piel/efectos de los fármacos , Piel/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Rayos Ultravioleta , Proteínas Virales , Administración Tópica , Adulto , Anciano , ADN Ligasas/farmacocinética , ADN Ligasas/farmacología , Reparación del ADN/efectos de los fármacos , Desoxirribonucleasa (Dímero de Pirimidina) , Portadores de Fármacos , Endodesoxirribonucleasas/farmacocinética , Endodesoxirribonucleasas/farmacología , Femenino , Humanos , Queratinocitos/enzimología , Células de Langerhans/enzimología , Liposomas , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Protectores contra Radiación/farmacocinética , Protectores contra Radiación/farmacología , Piel/efectos de la radiación , Piel/ultraestructura , Factores de Tiempo , Regulación hacia Arriba/efectos de los fármacos
3.
Cancer Res ; 52(15): 4227-31, 1992 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-1638536

RESUMEN

UV exposure has been linked to skin cancer in humans by epidemiology and the rare genetic disease xeroderma pigmentosum. However, UV produces multiple photoproducts in DNA, and their relative contribution is uncertain. An enzyme which specifically repairs cyclobutane pyrimidine dimers in DNA, T4 endonuclease V, was encapsulated in liposomes for topical delivery into mouse and human skin. In both species, liposomes applied after UV exposure localized in the epidermis and stimulated the removal of cyclobutane pyrimidine dimers. UV-irradiated mice treated with these liposomes had a dose-dependent decrease in the incidence of squamous cell carcinoma compared to controls. The results demonstrate that unrepaired cyclobutane pyrimidine dimers in DNA are a direct cause of cancer in mammalian skin.


Asunto(s)
Reparación del ADN , Endodesoxirribonucleasas/administración & dosificación , Endodesoxirribonucleasas/uso terapéutico , Neoplasias Inducidas por Radiación/prevención & control , Neoplasias Cutáneas/prevención & control , Piel/efectos de la radiación , Rayos Ultravioleta , Proteínas Virales , Animales , Daño del ADN , Desoxirribonucleasa (Dímero de Pirimidina) , Portadores de Fármacos , Endodesoxirribonucleasas/farmacocinética , Femenino , Humanos , Liposomas , Ratones , Ratones Pelados , Neoplasias Inducidas por Radiación/etiología , Técnicas de Cultivo de Órganos , Dímeros de Pirimidina/análisis , Piel/patología , Neoplasias Cutáneas/etiología , Fagos T/enzimología , Distribución Tisular
4.
Biochemistry ; 29(24): 5711-8, 1990 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-2200513

RESUMEN

Human cell free extract prepared by the method of Manley et al. (1980) carries out repair synthesis on UV-irradiated DNA. Removal of pyrimidine dimers by photoreactivation with DNA photolyase reduces repair synthesis by about 50%. With excess enzyme in the reaction mixture photolyase reduced the repair signal by the same amount even in the absence of photoreactivating light, presumably by binding to pyrimidine dimers and interfering with the binding of human damage recognition protein. Similarly, the UvrB subunit of Escherichia coli (A)BC excinuclease when loaded onto UV-irradiated or psoralen-adducted DNA inhibited repair synthesis by cell-free extract by 75-80%. The opposite was true also as HeLa cell free extract specifically inhibited the photorepair of a thymine dimer by DNA photolyase and its removal by (A)BC excinuclease. Cell-free extracts from xeroderma pigmentosum (XP) complementation groups A and C were equally effective in blocking the E. coli repair proteins, while extracts from complementation groups D and E were ineffective in blocking the E. coli enzyme. These results suggest that XP-D and XP-E cells are defective in the damage recognition subunit(s) of human excision nuclease.


Asunto(s)
Reparación del ADN , ADN/efectos de los fármacos , Desoxirribodipirimidina Fotoliasa/farmacología , Endodesoxirribonucleasas/farmacocinética , Proteínas de Escherichia coli , Escherichia coli/enzimología , Liasas/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Unión Competitiva , Prueba de Complementación Genética , Células HeLa , Humanos , Dímeros de Pirimidina/biosíntesis , Saccharomyces cerevisiae/enzimología , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA